Mandelli, F <br/><br/>
Use of interleukin-2 in the management of haematological malignancies: focus on minimal residual disease.  [electronic resource] 

 -  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy  Jul 1999 
 - 43-53 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1173-8804 
<br/><br/><label>Standard No.: </label>10.2165/00063030-199912010-00005  doi